Abstract
Upper respiratory tract infections are a frequent cause of illness. In children, acute otitis media (AOM) is the most common illness for which children receive medical attention. In adults, 20 million cases of bacterial sinusitis are reported yearly and the disease represents the fifth most common diagnosis for which an antibiotic is prescribed [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McCraig LF, Hughes JM (1995) Trends in antimicrobial drug prescription among office-based physicians in the United States. JAMA 273: 214–219
Hooper DC, Wolfson JS (1991) Fluoroquinolone antimicrobial agents. New England J Med 324: 384–394
Norrby SR (1991) Side-effects of quinolones: comparison between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 10: 378–383
Nuutinen M, Turtinen J, Uhari M (1994) Growth and joint symptoms in children treated with nalidixic acid. Pediatr Infect Dis J 13: 798–800
Hampel B, Hullmann R, Schmidt H (1977) Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use-safety report. Pediatr Infect Dis J 16: 127–129
Burkhardt JE, Walterspiel JN, Schaad UB (1997) Quinolone arthropathy in animals versus children. Clin Infect Dis 25: 1196–1204
Faden H, Duffy L, Boeve M (1998) Otitis media: back to basics. Pediatr Infect Dis J 17: 1105–1113
Lanphear BP, Byrd RS, Awinger P, Hall CB (1997) Increasing prevalence of recurrent acute otitis media among children in the United States. Pediatrics 99(3): El
Kaleida PH, Casselbrandt ML, Rockette HE et al (1991) Amoxicillin or miringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics 87: 466–474
Dagan R (2000) Clinical significance of resistant organisms in otitis media. Pediatr Infect Dis J 19: 378–382
Appelbaum PC (1992) Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15: 77–83
Jacobs MR (1996) Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 15: 940–943
Jacobs MR, Dagan R, Appelbaum PC, Burch DJ (1998) Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother 42: 589–595
Dowell SF, Butler JC, Giebink SG et al (1999) Acute otitis media: management and surveillance in an era of pneumococcal resistance-a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J 18: 1–9
Leibovitz E, Raiz S, Piglansky L et al (1998) Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J 17: 463–469
Perry CM, Barman Balfour JA, Lamb HM (1999) Gatifloxacin. Drugs 58: 683–696
Hoelmann DB, Lin G, Jacobs MR, Appelbaum PC (1999) Antipneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents. JAntimicrob Chemother 43: 645–649
Fukuda H, Hiramatsu K (1999) Primary targets of fluoroquinolones in Streptococcus pneumoniae. Antimicrob Agents Chemother 43: 410–412
Leibovitz E, Piglansky L, Raiz S et al (2001) Bacteriological efficacy of gatifloxacin in the treatment of recurrent/non-responsive acute otitis media. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, December 16–19, 2001, Chicago, MI (abstract 1558a)
Dagan R, Piglansky L, Greenberg D et al (2001) Dynamics of nasopharyngeal pneumococcal carriage in children with recurrent and non-responsive acute otitis media treated with gatifloxacin. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, December 16–19, 2001, Chicago, MI (abstract G-1825)
Arguedas A, Sher L, Lopez E, Saez-Llorens X, Skuba K, Pierce P (2001) Gatifloxacin treatment of recurrent/non-responsive acute otitis media. In: Program and abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, December 16–19, 2001, Chicago, MI (abstract 1534)
Celin S, Bluestone C, Stephenson J et al (1991) Bacteriology of acute otitis media in adults. JAMA 266: 2249–2252
Hiss DM, Shoham I, Leiberman A, Dagan R (1991) Chronic suppurative otitis media without cholesteatoma in children in Southern Israel. Pediatr Infect Dis J 10: 895–899
Hiss DM, Dagn R, Meidan N, Leiberman A (1992) Aerobic bacteriology of chronic suppurative otitis media without cholesteatoma in children. Ann Otol Rhinol Laryngol 101: 866–869
Sabella C (2000) Mangement of otorrhea in infants and children. Pediatr Infect Dis J 19: 1007–1008
Ghosh S, Panarese A, Parker AJ, Bull PD (2000) Quinolone ear drops for chronic otitis media. They are safer and more effective than aminoglycosides. BMJ 321: 126–127
Acuin J, Smith A, Mc Kenzie I (1999) Interventions for chronic suppurative otitis media. In: Cochrane Collaboration. Cochrane Library. Issue 4. Oxford: Update Software
Lang R, Goshen S, Raas-Rothschild A, Raz A, Ophir D, Wollach B, Berger I (1992) Oral ciprofloxacin in the management of chronic suppurative otitis media without cholesteatoma in children: preliminary experience in 21 children. Pediatr Infect Dis J 11: 925–929
Gehanno P (1994) Ciprofloxacin in the treatment of malignant external otitis. Chemotherapy 40: 35–40 (suppl 1)
Wald ER (1998) Microbiology of acute and chronic sinusitis in children and adults. Am J Med Sci 316: 13–20
Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 123: S4–32
Weiss M, Hendrick K, Tillotson G, Gravelle K, the Rhinosinusitis Investigation Group (1998) Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Clin Therap 20: 921–931
Syndor TA, Kopp EJ, Anthony KE, LoCoco JM, Kim SS, Fowler CL (1998) Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. Ann Allergy Asthma Immunol 80: 357–362
Adelgass J, Jones TM, Ruoff G et al (1998) A multicenter, investigator-blinded, randomized comparison of oral levofloxacin an oral clarithromycin in the treatment of acute bacterial sinusitis. Pharmacotherapy 18: 1255–1263
Adelglass J, DeAbate CA, McElvaine P, Fowler CL, LoCocco J, Campbell T (1999) Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. Otolaryngol Head Neck Surg 120: 320–327
Sisniega J, Jones RW, Kaminszczik G et al (1999) Treating acute, uncomplicated bacterial sinusitis with gatifloxacin. J Resp Dis 20: S11–16
Fogarty C, McAdoo MA, Paster RZ, Martel AY, Macko AC, Breen J (1999) Gatifloxacin versus clarithromycin in the management of acute sinusitis. J Resp Dis 20: S23–29
Winther B, Vickery CL, Gross CW, Hendley JO (1996) Microbiology of the maxillary sinus in adults with chronic sinus disease. Am J Rhino! 10: 347–350
Legent F, Bordure P, Beauvillain C, Berche P (1994) A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 40 suppl 1: 8–15
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Basel AG
About this chapter
Cite this chapter
Leibovitz, E., Dagan, R. (2003). The quinolones in otitis media and upper respiratory infections. In: Ronald, A.R., Low, D.E. (eds) Fluoroquinolone Antibiotics. Milestones in Drug Therapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8103-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8103-6_9
Published:
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9437-1
Online ISBN: 978-3-0348-8103-6
eBook Packages: Springer Book Archive